27
February
0
Comments
Pomerantz To Rep Investors In Acadia Drug Deaths Case
in Legal News
Law360 (February 27, 2019, 5:17 PM EST) — Pomerantz LLP has been appointed as lead counsel in a proposed securities fraud class action alleging Acadia Pharmaceuticals Inc. inflated its stock price by hiding safety risks and downplaying reports of…
